Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

203.80
-1.2700-0.62%
Volume:2.11M
Turnover:433.05M
Market Cap:360.19B
PE:86.36
High:208.62
Open:208.06
Low:203.24
Close:205.07
52wk High:244.81
52wk Low:164.39
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.40
T/O Rate:0.12%
Dividend:6.65
Dividend Rate:3.26%
EPS(TTM):2.36
EPS(LYR):2.36
ROE:6225.00%
ROA:9.81%
PB:-110.15
PE(LYR):86.36

Loading ...

BUZZ-Xilio rises after surprise quarterly profit

Reuters
·
Yesterday

Xilio Therapeutics posts Q4 profit on higher collaboration revenue

Reuters
·
Yesterday

Xilio Therapeutics Q4 license revenue rose 100% to USD 14 million, net income was USD 10 million

Reuters
·
Yesterday

Basilea Pharmaceutica AG publishes investor presentation on anti-infective portfolio and pipeline development

Reuters
·
Yesterday

AbbVie Stock Slides as Insider Selling Spooks Investors

TIPRANKS
·
Mar 21

US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings

Reuters
·
Mar 21

Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie

Benzinga_recent_news
·
Mar 19

BNP Paribas: J&J's New Psoriasis Drug Enters Market, Posing Challenge to AbbVie's Blockbuster Skyrizi

Stock News
·
Mar 19

Allergan Aesthetics to present AA Signature framework update at AMWC 2026 in Monaco

Reuters
·
Mar 19

AbbVie Inc. Stock Slips 5.2%, Underperforms Peers

Dow Jones
·
Mar 19

BUZZ-AbbVie falls as J&J psoriasis pill raises competition risk

Reuters
·
Mar 19

REFILE-US STOCKS-Wall Street remains lower after Fed keeps rates unchanged

Reuters
·
Mar 19

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Reuters
·
Mar 19

AbbVie On Track for Lowest Close Since May 2025 -- Data Talk

Dow Jones
·
Mar 19

What's Going On With AbbVie Stock Today?

Benzinga_recent_news
·
Mar 19

Abbvie Shares Down 3.2% After US FDA Approves Johnson & Johnson's Oral Psoriasis Pill

THOMSON REUTERS
·
Mar 18

BRIEF-Alloy Therapeutics Agreement With AbbVie To Develop A New Antibody Platform

Reuters
·
Mar 17

Alloy Therapeutics: Agreement With Abbvie to Develop a New Antibody Platform

THOMSON REUTERS
·
Mar 17

Alloy Therapeutics: as Part of Multi-Year Deal, Co to GET Upfront Payment, & Additional Payment in Connection With Delivery of Platform to Abbvie

THOMSON REUTERS
·
Mar 17

Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Mar 16